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Edited by Beat ImhofAbstract To understand physiological roles of tissue mast cells,
we established a culture system where bone marrow-derived
immature mast cells diﬀerentiate into the connective tissue-type
mast cell (CTMC)-like cells through modifying the previous
co-culture system with Swiss 3T3 ﬁbroblasts. Our system was
found to reproducibly mimic the diﬀerentiation of CTMCs on
the basis of several criteria, such as granule maturation and sen-
sitivity to cationic secretagogues. The gene expression proﬁle ob-
tained by the microarray analyses was found to reﬂect many
aspects of the diﬀerentiation. Our system is thus helpful to gain
deeper insights into terminal diﬀerentiation of CTMCs.
 2008 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Mast cells play critical roles not only in anaphylactic
responses but also in modulation of diverse innate and
acquired immune responses [1,2]. Mast cells originate from
hematopoietic progenitor cells and undergo terminal diﬀerenti-
ation in tissues where they are resident [3]. It is of great interest
to investigate the terminal diﬀerentiation process of mast cells
in each tissue, since modulation of local immune responses by
mast cells should be inﬂuenced by their heterogeneity. How-
ever, little information is currently available about the hetero-
geneity and local maturation of tissue mast cells.Abbreviations: BMMC; bone marrow-derived mast cell; CTMC;
connective tissue mast cell; MMC; mucosal mast cell
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tions: connective tissue mast cells (CTMCs) and mucosal mast
cells (MMCs) [3,4]. CTMCs are represented by cutaneous
and peritoneal mast cells and are characterized by abundant
cellular histamine and heparin contents and degranulation in
response to cationic secretagogues. Since recent studies dem-
onstrated that CTMCs are involved in a wide variety of
immune responses, such as autoimmunity [5], contact hyper-
sensitivity [6], and immune tolerance [7], in addition to ana-
phylactic responses, detailed analysis and characterization of
CTMCs are required. To establish experimental models for
CTMCs, an array of attempts has been made using various
sources, such as IL-3-dependent bone marrow-derived mast
cells (BMMCs) [8,9] and fetal skin cells [10]. However, it
remains to be clariﬁed how immature mast cell precursors
are diﬀerentiated into CTMCs and what kinds of genes regu-
late this process. To address these questions, we established
suitable culture system to develop CTMC-like mast cells by
modifying the previous methods, and thereby performed
microarray analysis of the gene expression proﬁle during the
in vitro terminal diﬀerentiation of mast cells.2. Materials and methods
2.1. Preparation of BMMCs
Speciﬁc-pathogen-free, 8–12 week-old female Balb/c mice were
obtained from Japan SLC (Hamamatsu, Japan). All animal experiments
were performed according to the Guidelines for Animal Experiments of
Kyoto University and Mukogawa Womens University. BMMCs were
prepared as described previously [11], using 10 ng/ml IL-3 (R&D
Systems, Minneapolis, MN) in place of WEHI-3 conditioned medium.
2.2. Co-culture of BMMCs with ﬁbroblasts
The co-culture system was established by modifying the previous
method [12]. Swiss 3T3 ﬁbroblasts were seeded with 50% conﬂuency
in the same RPMI-1640 medium as BMMCs, treated with 3 lg/ml
mitomycin C (Sigma, St. Louis, MO) for 3 h, and further incubated
for 3 h in the fresh medium without mitomycin C. BMMCsation of European Biochemical Societies.
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ture for 4 days in the presence of 100 ng/ml stem cell factor (SCF),
which was supplied as the conditioned medium of Sf9 cells infected
with the recombinant baculovirus encoding murine SCF [12]. An equal
volume of the fresh medium containing 100 ng/ml SCF was added at
Day-2. When the feeder cells were replaced at Day-4, whole culture
was trypsinized and the contaminating ﬁbroblasts were removed as
the adhered cells through repeated plating.
2.3. Protease assay
Mast cells were washed with PBS, lysed in PBS containing 2 M NaCl
and 0.5% Triton X-100, and incubated for 30 min on ice. The lysate
was centrifuged at 10000 · g for 30 min at 4 C. Activities of three dif-
ferent types of granule proteases in the resultant supernatants were
measured using their speciﬁc chromogenic peptide substrates, such as
S-2586 (tryptic), S-2288 (chymotryptic), and M-2245 (carboxypepti-
dase A) [13].
2.4. Degranulation
Mast cells were washed with PIPES buﬀer (25 mM PIPES–NaOH,
pH 7.4, containing 125 mM NaCl, 2.7 mM KCl, 5.6 mM glucose,
1 mM CaCl2, and 0.1% bovine serum albumin) and incubated with
the buﬀer containing compound 48/80 (10 lg/ml, Sigma), substance
P (100 lM, Sigma), or A23187 (1 lM, Calbiochem, Darmstadt, Ger-
many) for 30 min. In case of antigen stimulation, mast cells sensitized
with 1 lg/ml an anti-DNP IgE (SPE-7, Sigma) for 6 h were stimulated
with 30 ng/ml DNP-human serum albumin (Sigma). Degranulation
was evaluated by measuring b-hexosaminidase activity.
2.5. Oligonucleotide microarray
Total cellular RNAs were isolated from mast cells using an RNeasy
mini kit (QIAGEN, Valencia, CA) according to the manufacturers
instructions. Target RNAs were prepared following technical recom-
mendations found in the Aﬀymetrix Gene Chip Expression Analysis
Technical Manual (Aﬀymetrix, Santa Clara, CA). The obtained RNAs
were labeled and hybridized to the 430A murine GeneChip (Aﬀyme-
trix), which contains the oligonucleotide probe set for approximately
22000 genes. We used the RMA (robust multi-array analysis) [14]
expression measure that represents the log transform of (background
corrected and normalized) intensities of the GeneChips. The RMA
measures were computed using the R package program, which is freely
available on the web site (http://www.bioconductor.org). We then re-
moved all genes whose maximum minus minimum values were less
than 2 (2-fold change), and selected 1315 genes, which were diﬀeren-
tially expressed between the cells during co-culture. Using the k-means
clustering algorithm, these genes were classiﬁed into 10 clusters on the
basis of similarity of their expression proﬁles.
2.6. Flow cytometry
The surface expression levels of FceRI were determined as described
previously [15]. For measuring the surface expression of IL-17Rs, mast
cells were pretreated with 2.4G2 (BD Biosciences, San Diego, CA)
were then treated with 20 lg/ml IL-17 (R&D Systems) at 4 C for
60 min. Labeling of the cells was performed by incubation with a phy-
coerythrin (PE)-conjugated anti-mouse IL-17 antibody (BD Biosci-
ences) at 4 C for 10 min. For measuring the expression of ICAM-1,
c-kit, or CD81, FITC-conjugated anti-ICAM-1, PE-conjugated anti-
c-kit, or anti-CD81 antibody (BD Biosciences) was used, respectively.
2.7. Immunoblot analyses
Immunoblot analysis was performed as described previously [11]
using antibodies raised against actin, Gai3 (Chemicon, Temecula,
CA), Gai1, Itk (Upstate Biotechnology, Charlottesville, VA), Gai2,
COX-2, GATA-1, c-Myb, Tiam1, Lyn (Santa Cruz, CA), and COX-
1 (Cayman Chemicals, Ann arbor, MI).
2.8. Measurement of cytosolic Ca2+ concentrations
Cytosolic Ca2+ concentrations were measured using Fura-2/AM as
described previously [11].
2.9. Puriﬁcation of peritoneal mast cells
Peritoneal mast cells were puriﬁed by means of MACS system in
accordance with the manufacturers instruction (Miltenyi Biotech,Bergisch Gladbach, Germany). Brieﬂy, mast cells were enriched using
the magnet-conjugated anti-c-kit antibody after depletion of the other
cell lineages using the antibodies against CD11b, CD45R, CD90, and
Ter119. The purity of mast cells was greater than 98% based on the
Safranin staining.3. Results and discussion
3.1. Changes in granule staining properties, protease activities,
and histamine content of cultured mast cells
We found in the preliminary experiments that the previously
reported co-culture methods to develop CTMC-like cells have
room for improvement in reproducibility. Since mast cells can
aﬀect growth of the feeder ﬁbroblasts and vice versa [16], a
slight change of the culture condition can lead to imbalance
of the number of mast cells and ﬁbroblasts, which often aﬀects
the process of maturation. We employed the mitomycin C
treatment to exclude such instability in the co-culture system.
Our method exhibited several advantages over the reported
methods using 3T3 ﬁbroblasts, in particular in terms of high
reproducibility and expandability, which allowed us to investi-
gate the changes over time. Although at Day-0, the majority of
cells (>90%) were stained with Alcian blue but not with Safra-
nin, the population of Safranin-positive mast cells was gradu-
ally increased up to 80% at Day-16 of the co-culture
(Fig. 1A). It is generally accepted that an increase in histamine
content and granule protease expression reﬂects maturation of
mast cells [17]. All the three kinds of granule protease activities
and the cellular histamine content were found to be gradually
increased (Fig. 1B–E). High levels of FceRI and c-kit were de-
tected on the surface of more than 95% of the cultured mast
cells throughout the co-culture period (Fig. 1F, and data not
shown).
A recent study described the generation of a large number of
high-purity CTMC-like mast cells from mouse fetal skin cells
[10]. Embryonic stem cell–derived mast cells have also been
found to be a good model for CTMCs [18]. However, it was
diﬃcult to investigate the changes during mast cell maturation
using these culture methods, since diﬀerentiation and matura-
tion of mast cells from progenitors occurs concurrently with
elimination of the other cell lineages. In contrast, we used
BMMCs, the vast majority of which expresses both c-kit and
FceRI, as the initial population to develop mature mast cells.
The changes observed in our system are therefore attributed
solely to those in the mast cell lineage.3.2. Gene expression proﬁle during maturation of cultured mast
cells
The characterization of the co-cultured mast cells suggested
that our system reﬂected the process of terminal diﬀerentiation
of CTMCs. We therefore performed the microarray analysis of
gene expression in the cultured mast cells to gain a deeper
appreciation on this process at the molecular levels. The num-
ber of genes, of which expression levels represent greater than
2-fold change, was 1315. These genes were classiﬁed into 10
groups by the clustering analysis (Fig. 2 and Supplementary
data).
Expression proﬁles of several genes appeared to correlate well
with characteristic changes concomitant with mast cell matura-
tion. (i) The drastic induction of mast cell protease genes (Mcpt)
is consistent with the increase in tryptic and chymotryptic activ-
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Fig. 1. Maturation of BMMCs co-cultured with ﬁbroblasts in the presence of SCF. (A) BMMCs co-cultured for 16 days were collected (Day-0, -4,
-8, -12, and -16) and stained with Alcian blue and Safranin-O. Bars = 10 lm. (B–E) Granule protease activities of the cells were measured
(B: chymotryptic activity, C: tryptic activity, D: carboxypeptidase A activity). Histamine content was also measured (E). Values are presented by the
means ± S.E.M. (n = 5). (F) Surface expression of FceRI and c-kit was determined by ﬂow cytometry.
1446 H. Takano et al. / FEBS Letters 582 (2008) 1444–1450ities (Fig. 1B and C). In addition, induction of other protease
genes, such as cathepsin B (Ctsb) and transmembrane tryptase
(Tpsg1), was also observed. (ii) Induction of histidine decarbox-
ylase (Hdc), which catalyzes histamine synthesis, is also consis-
tent with the increase in cellular histamine content (Fig. 1E). (iii)
Heparan sulfate biosynthesis is mediated by an array of enzymes
[19]. We found the increased gene expression of these enzymes,
including exostoses 1 (Ext1), and heparan sulfate 6-O-sulfo-
transferase 2 (Hs6st2), which mediates synthesis of polysaccha-
ride backbone and 6-O-sulfation after N-deacetylation and
N-sulfation of N-acetyl glucosamine, respectively. Glucosami-
nyl N-deacetylase/N-sulfotransferase-2 (Ndst2) is known to be
essential for heparin biosynthesis in mast cells, and peritoneal
mast cells in theNDST-2-deﬁcient mice exhibit aberrant granule
morphology and decreased granule proteases [13,20]. However,
we unexpectedly found a decrease in the NDST-2 gene expres-
sion duringmaturation. Analysis of these enzymes at the protein
level is surely required to address this inconsistency. (iv) As for
arachidonic acid metabolism, up-regulation of hematopoieticprostaglandin (PG) D synthase (Ptgds2) and down-regulation
of leukotriene (LT) C4 synthase (Ltc4s) are consistent with the
previous report indicating the production of PGD2 in preference
to LTC4 in CTMCs [17]. Given that CTMCs adhere to the
extracellular matrix in the tissues, it is interesting that up-
regulation of the genes related to adhesion, such as integrins
(Itga5, Itga9, and Itgb1), CD44 (Cd44), and ICAM-1 (Icam1),
was detected during the co-culture period. Altogether, these
changes in the gene expression are in good accordance with phe-
notypic changes observed during mast cell maturation, indicat-
ing that our culture system successfully mimics the maturation
process.
Immunoblot analyses conﬁrmed that the changes in the
expression of various proteins paralleled those of the corre-
sponding gene expression in the microarray analyses (Fig. 2A
and B). GATA-1 and GATA-2 were reported to be required
for mast cell diﬀerentiation [21,22]. Recently, Masuda et al.
demonstrated that these transcription factors are required for
maintaining mast cell-speciﬁc gene expression and are required
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observed, however, a drastic GATA-1 down-regulation during
the later stage of co-culture period (Fig. 2B), indicating that
GATA-1 may be dispensable for the ﬁnal step of mast cell mat-
uration.
We then analyzed expression of several membrane proteins,
including CD81, ICAM-1, and the IL-17 receptor (IL-17R), by
ﬂow cytometry (Fig. 2C). CD81 was one of the strikingly up-
regulated genes during the co-culture period (supplemental
data). Since Yamada et al. demonstrated that the higher sur-
face expression of CD81 is one of the signatures of cutaneous
mast cells [10], it is likely that the drastic up-regulation at Day-
16 reﬂects the diﬀerentiation towards CTMC-like cells. The
surface expression of ICAM-1 was also conﬁrmed to be up-
regulated in the Day-16 cultured mast cells. Consistent with
induction of the IL-17R gene on the microarray analysis
(Fig. 2A, clusters #1 and #3, Il17r), the surface expression of
IL-17R, which was detectable on BMMCs, was signiﬁcantly
up-regulated in the Day-16 cultured mast cells. Nakae et al.
demonstrated that IL-17 enhanced ionomycin-induced TNF-
a production in BMMCs, although IL-17 alone failed to in-
duce TNF-a [24]. IL-17R may determine the sensitivity to
IL-17 in mature tissue mast cells. Our results indicate that
these membrane proteins are good candidates for the surface
marker of CTMCs.E
1
2
5
1
2
5
Day-0 Day-16
R
at
io
 (E
x 
34
0/
38
0)
R
at
io
 (E
x 
34
0/
38
0)
Day
0 4 8 12 16
Gαi1
Gαi2
Gαi3
F3.3. Comparison of gene expression proﬁles between cultured
mast cells and peritoneal mast cells
We compared the gene expression proﬁle of the Day-16 co-
cultured mast cells with that of peritoneal mast cells, which are
regarded as typical CTMCs. The characteristic changes in gene
expression proﬁle between the Day-0 and Day-16 co-cultured
mast cells were also conﬁrmed in the case of the comparison
between BMMCs (Day-0) and peritoneal mast cells; approxi-
mately 70% of the extracted genes (511 genes in 732 genes; par-
allel increase in clusters 0 and 1, parallel decrease in clusters 5,
6, and 7), of which diﬀerences in expression values were greater
than 2-fold between Day-0 and Day-16 co-cultured mast cells,
exhibited similar trends in the peritoneal mast cells (Fig. 2D).
This result suggests that the approach with the co-culture sys-
tem can eﬃciently select the genes, of which expression is char-
acteristic of CTMCs.Actin
Fig. 3. Cationic secretagogue-induced degranulation and Gai expres-
sion. (A–D) Co-cultured mast cells were separated and stimulated with
1 lMA23187 (B), 10 lg/ml compound 48/80 (C), or 100 lM substance
P (D). In case of IgE-mediated antigen stimulation, the sensitized mast
cells were stimulated with the antigen as described in Section 2 (A).
Values are presented by the means ± S.E.M. (n = 5). (E) Intracellular
Ca2+ mobilization was monitored using Fura-2/AM. BMMCs (Day-0)
and co-cultured mast cells (Day-16) were stimulated with 10 lg/ml
compound 48/80 (indicated by the arrows). These are the representa-
tives of three similar independent experiments. Bars = 1 min. (F)
Expression of three Gai subtypes in the co-cultured mast cells at each
time point was examined by immunoblot analyses. An anti-actin
antibody was used as a loading control.3.4. Degranulation of cultured mast cells in response to cationic
secretagogues
BMMCs and the co-cultured mast cells responded to IgE-
mediated antigen stimulation in a similar fashion up to Day-
12 (Fig. 3A). A signiﬁcant decrease in degranulation was found
at Day-16, which may be attributed to up-regulation of the
molecules that can suppress activation of mast cells upon
IgE-mediated antigen stimulation, such as FccRIIB, Rab-
GEF1, and CD81 (Fig. 2A, clusters #1 and #3) [25–27]. The
constant levels of degranulation in response to a Ca2+ iono-
phore, A23187, were observed, indicating that the process of
Ca2+ inﬂux-mediated degranulation was not aﬀected during
the co-culture period (Fig. 3B).
CTMCs can be distinguished from MMCs or BMMCs in
their sensitivity to cationic secretagogues, such as compound
48/80. At Day-16, the cultured mast cells released 60% and
40% of b-hexosaminidase activity in response to compound
48/80 and substance P, respectively, whereas no or little releasefrom BMMCs (Day-0) was detected (Fig. 3C and D). Since a
previous study demonstrated that compound 48/80 causes
intracellular Ca2+ mobilization in mast cells [28], we then exam-
ined cytosolic Ca2+ response to the secretagogue. As expected,
compound 48/80 increased the cytosolic Ca2+ concentrations in
H. Takano et al. / FEBS Letters 582 (2008) 1444–1450 1449the Day-16 cultured mast cells, but not in BMMCs (Day-0)
(Fig. 3E).
Degranulation induced by basic secretagogues was reported
to be mediated by the heterotrimeric G protein, Gi, especially
by Gi3, in rat peritoneal mast cells [29]. Ferry et al. suggested
that the bc subunits of Gi2 and Gi3 induced degranulation
through activating phospholipase Cb [30]. Furthermore, a re-
cent study using cultured human mast cells revealed that the
Gai3 protein was induced upon co-culture with 3T3 ﬁbroblasts
and suggested an involvement of Gi3 in eosinophil major basic
protein-induced degranulation [31]. We then examined the lev-
els of three Gai subtypes (Fig. 3F). In good agreement with the
microarray results (Fig. 2A, cluster #3, Gnai1), the level of the
Gai1 protein was drastically increased during the co-culture
period, whereas the level of Gai2 or Gai3 was not signiﬁcantly
changed. Furthermore, the Gai1 induction is well correlated
with the elevated degranulation in response to compound 48/
80 (Fig. 3C). Previous studies using basic secretagogues have
paid little attention to the Gai1 protein, since they mostly used
rat peritoneal mast cells, which lack the expression of Gai1.
Our results suggest that Gai1 is a potent candidate for the reg-
ulator of basic secretagogue-induced degranulation in mouse
mast cells.
3.5. Conclusion
In summary, we succeeded in improving the culture system
to develop the CTMC-like mast cells. This system allows us
to investigate the gene expression proﬁles during maturation
of mast cells, which should contribute to understanding the
mechanism underlying mast cell terminal diﬀerentiation.
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